Submission for OMB Review; Comment Request; Cancer Trials Support Unit (CTSU) Public Use Forms and Customer Satisfaction Surveys (NCI), 66767-66769 [2010-27330]

Download as PDF 66767 Federal Register / Vol. 75, No. 209 / Friday, October 29, 2010 / Notices To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, access CMS’ Web site at https://www.cms.hhs.gov/ PaperworkReductionActof1995, or Email your request, including your address, phone number, OMB number, and CMS document identifier, to Paperwork@cms.hhs.gov, or call the Reports Clearance Office on (410) 786– 1326. In commenting on the proposed information collections please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in one of the following ways by December 28, 2010: 1. Electronically. You may submit your comments electronically to https:// www.regulations.gov. Follow the instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection document(s) accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: Document Identifier/OMB Control Number, Room C4–26–05, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. Dated: October 26, 2010. Martique Jones, Director, Regulations Development Group, Division B, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2010–27470 Filed 10–28–10; 8:45 am] BILLING CODE 4120–01–P Attach No. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; Comment Request; Cancer Trials Support Unit (CTSU) Public Use Forms and Customer Satisfaction Surveys (NCI) Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Cancer Institute (NCI), the National Institutes of Health (NIH), has submitted to the Office of Management and Budget (OMB) a request to review and approve the information collection listed below. This proposed information collection was previously published in the Federal Register on July 13, 2010 (75 FR 39950) and allowed 60-days for public comment. There have been no public comments. Additionally, the 30-day Federal Register was published on September 13, 2010. The purpose of this notice is to allow an additional 30 days for public comment to the revisions. The National Institutes of Health may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Proposed Collection: Title: Cancer Trial Support Unit (CTSU). Type of Information Collection Request: Existing Collection in Use Without an OMB Number. Need and Use of Information Collection: CTSU collects annual surveys of customer satisfaction for clinical site staff using the CTSU Help Desk and the CTSU Web site. An ongoing user satisfaction survey is in place for the Oncology Patient SUMMARY: Use metrics/ month— # respond Section/form or survey title Estimated time for site to complete (minutes) Enrollment Network (OPEN). User satisfaction surveys are compiled as part of the project quality assurance activities and used to direct improvements to processes and technology. In addition, the CTSU collects standardized forms to process site regulatory information, changes to membership, patient enrollment data, and routing information for case report forms. This questionnaire adheres to The Public Health Service Act, Section 413 (42 U.S.C. 285a–2) authorizes CTEP to establish and support programs to facilitate the participation of qualified investigators on CTEP-supported studies, and to institute programs that minimize redundancy among grant and contract holders, thereby reducing overall cost of maintaining a robust treatment trials program. Based on a conversation with the Office of Management and Budget on October 17, 2010, the burden table has been revised to take into account future submissions of a generic data transmittal forms (see Attachment 1gg in the Table below). It was agreed that the generic forms will be finalized and submitted in the future as non-substantive change requests for OMB clearance as needed. Frequency of Response: The help desk and Web site survey are collected annually. The OPEN survey is ongoing. The form submissions vary depending on the purpose of the form and the activity of the local site. Affected Public: CTSU’s target audience is staff members at clinical sites and CTEP-supported programs. Respondent and burden estimates are listed in the Table below. The annualized burden is estimated to be 34,802 hours and the annualized cost to respondents is estimated to be $946, 601. There are no Capital Costs, Operating Costs, and/or Maintenance Costs to report. Estimated burden (minutes/ hours) Frequency of response Total annual usage/annual burden hours Regulatory/Roster 1a .......... WReier-Aviles on DSKGBLS3C1PROD with NOTICES 1b .......... 1c .......... 1d .......... CTSU IRB/Regulatory Approval Transmittal Form. CTSU IRB Certification Form ........................... CTSU Acknowledgement Form ........................ Optional Form 1—Withdrawal from Protocol Participation Form. 9,000 2 0.03 12.00 3,600 8,500 500 50 10 5 5 0.17 0.08 0.08 12.00 12.00 12.00 17,000 500 50 50 20 2–4 30 0.07 0.50 12.00 12.00 40 120 Roster Forms 1e .......... 1f ........... CTSU Roster Update Form .............................. CTSU Radiation Therapy Facilities Inventory Form. Drug shipment VerDate Mar<15>2010 15:23 Oct 28, 2010 Jkt 223001 PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 E:\FR\FM\29OCN1.SGM 29OCN1 66768 Federal Register / Vol. 75, No. 209 / Friday, October 29, 2010 / Notices Estimated time for site to complete (minutes) Use metrics/ month— # respond Attach No. Section/form or survey title 1g .......... 1h .......... CTSU IBCSG Drug Accountability Form .......... CTSU IBCSG Transfer of Investigational Agent Form. Estimated burden (minutes/ hours) Frequency of response Total annual usage/annual burden hours 11 3 5–10 20 0.17 0.33 12.00 12.00 22 12 100 1000 75 5–10 5–10 5–10 0.17 0.17 0.17 12.00 12.00 12.00 200 2,000 150 2100 5–10 0.17 12.00 4,200 650 75 15–20 5–10 0.33 0.17 12.00 12.00 2,600 150 50 50 50 75 60 50 10 50 100 10 5–10 5–10 5–10 5–10 5–10 5–10 5–10 5–10 5–10 5–10 0.17 0.17 0.17 0.17 0.17 0.17 0.17 0.17 0.17 0.17 12.00 12.00 12.00 12.00 12.00 12.00 12.00 12.00 12.00 12.00 100 100 100 150 120 100 20 100 200 20 50 5–10 0.17 12.00 100 5 5–10 0.17 12.00 10 600 30 40 5–10 5–10 5–10 0.17 0.17 0.17 12.00 12.00 12.00 1,200 60 80 50 35 130 500 15–20 10 5–10 5–10 0.33 0.17 0.17 0.17 12.00 12.00 12.00 12.00 200 70 260 1000.00 250 300 120 10–15 10–15 10–15 0.2500 0.2500 0.2500 1.00 1.00 1.00 63 75 30 Data Management 1i ........... 1j ........... 1k .......... 1l ........... 1m ......... 1n .......... 1o .......... 1p .......... 1q .......... 1r ........... 1s .......... 1t ........... 1u .......... 1v .......... 1w ......... 1x .......... 1y .......... 1z .......... Site Initiated Data Update Form (generic) ....... N0147 CTSU Data Transmittal Form ............... Site Intimated Data Update Form (DUF), Protocol: NCCTG N0147*. TAILORX/PACCT 1 CTSU Data Transmittal Form. Data Clarification Form ..................................... Unsolicited Data Modification Form (UDM), Protocol: TAILORx/PACCT1. Z4032 CTSU Data Transmittal Form ............... Z1031 CTSU Data Transmittal Form ............... Z1041 CTSU Data Transmittal Form ............... Z6051 CTSU Data Transmittal Form ............... RTOG 0834 CTSU Data Transmittal Form* .... CTSU 7868 Data Transmittal Form ................. Site Initiated Data Update Form, protocol 7868 MC0845(8233) CTSU Data Transmittal* .......... 8121 CTSU Data Transmittal Form* ................ Site Initiated Data Update Form, Protocol 8121. USMCI 8214/Z6091: CTSU Data Transmittal .. *In Development ............................................... USMCI 8214/Z6091 Crossover Request/ Checklist Transmittal Form. Patient Enrollment 1aa ........ 1bb ........ 1cc ........ CTSU Patient Enrollment Transmittal Form ..... CTSU P2C Enrollment Transmittal Form ......... CTSU Transfer Form ........................................ Administrative 1dd ........ 1ee ........ 1ff .......... 1gg ........ CTSU CTSU CTSU CTSU System Account Request Form ............ Request for Clinical Brochure ............... Supply Request Form ............................ Generic Data Transmittal Form ............. Surveys/Web Forms 2 ............ 3 ............ 4 ............ CTSU Web Site Customer Satisfaction Survey CTSU Helpdesk Customer Satisfaction Survey CTSU OPEN Survey ........................................ WReier-Aviles on DSKGBLS3C1PROD with NOTICES Annual Totals .......... 21,770 ............................................................... Request for Comments: Written comments and/or suggestions from the public and affected agencies should address one or more of the following points: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; VerDate Mar<15>2010 15:23 Oct 28, 2010 Jkt 223001 34,802 (3) Enhance the quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 time, should be directed to the Attention: NIH Desk Officer, Office of Management and Budget, at OIRA_submission@omb.eop.gov or by fax to 202–395–6974. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact Michael Montello, Pharm. D., CTEP, 6130 Executive Blvd., Rockville, MD 20852, call non-toll-free number 301–435–9206 or e-mail your request, including your address to: montellom@mail.nih.gov. E:\FR\FM\29OCN1.SGM 29OCN1 Federal Register / Vol. 75, No. 209 / Friday, October 29, 2010 / Notices Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. Dated: October 21, 2010. Vivian Horovitch-Kelley, NCI Project Clearance Liaison, National Institutes of Health. [FR Doc. 2010–27330 Filed 10–28–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2010–D–0378] Draft Compliance Policy Guide Sec. 690.800 Salmonella in Animal Feed; Availability; Extension of Comment Period I. Background In the Federal Register of August 2, 2010 (75 FR 45130), FDA published a notice of availability of a draft CPG with a 90-day comment period to request comments on its proposal that certain criteria should be considered in recommending enforcement action against animal feed or feed ingredients that are adulterated due to the presence of Salmonella. The Agency has received a request for a 60-day extension of the comment period for the draft CPG. The request conveyed concern that the current 90-day comment period does not allow sufficient time to develop a meaningful or thoughtful response to the draft CPG. FDA has considered the request and is extending the comment period for the draft CPG for 60 days, until December 31, 2010. period. The Food and Drug Administration (FDA) is extending to December 31, 2010, the comment period for a notice of availability of a draft compliance policy guide (CPG) that appeared in the Federal Register of August 2, 2010 (75 FR 45130). In the document, FDA requested comments on its proposal that certain criteria should be considered in recommending enforcement action against animal feed or feed ingredients that are adulterated due to the presence of Salmonella. The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments. II. Request for Comments Interested persons may submit to the Division of Dockets Management (see ADDRESSES) either electronic or written comments on this document. It is only necessary to send one set of comments. It is no longer necessary to send two copies of mailed comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. Dated: October 26, 2010. Dara Corrigan, Associate Commissioner for Regulatory Affairs. AGENCY: Food and Drug Administration, HHS. ACTION: Notice; extension of comment SUMMARY: Submit either electronic or written comments by December 31, 2010. DATES: Submit electronic comments on the draft CPG to https:// www.regulations.gov. Submit written comments on the draft CPG to the Division of Dockets Management (HFA– 305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. WReier-Aviles on DSKGBLS3C1PROD with NOTICES ADDRESSES: Kim Young, Center for Veterinary Medicine (HFV–230), Food and Drug Administration, 7519 Standish Pl., MPN–4, rm. 106, Rockville, MD 20855, 240–276–9200, e-mail: Kim.young@fda.hhs.gov. FOR FURTHER INFORMATION CONTACT: SUPPLEMENTARY INFORMATION: VerDate Mar<15>2010 15:23 Oct 28, 2010 Jkt 223001 [FR Doc. 2010–27448 Filed 10–28–10; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), and pursuant to the requirements of 42 CFR 83.15(a), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Board Public Meeting Times and Dates (All Times Are Mountain Time) 8:15 a.m.–5:15 p.m., November 16, 2010. PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 66769 8:15 a.m.–5:15 p.m., November 17, 2010. 8:15 a.m.–12 p.m., November 18, 2010 Public Comment Times and Dates (All Times Are Mountain Time) 5:30 p.m.–7 p.m.,* November 16, 2010. 5:30 p.m.–6:30 p.m.,* November 17, 2010. *Please note that the public comment periods may end before the times indicated, following the last call for comments. Members of the public who wish to provide public comments should plan to attend public comment sessions at the start times listed. Place: Hilton Santa Fe Historic Plaza, 100 Sandoval Street, Santa Fe, New Mexico; Phone: 505–988–2811; Fax: 505–986–6439. Audio Conference Call via FTS Conferencing. The USA toll-free dial-in number is 1–866–659–0537 with a pass code of 9933701. Status: Open to the public, limited only by the space available. The meeting space accommodates approximately 150 people. Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program (EEOICP) Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and will expire on August 3, 2011. Purpose: This Advisory Board is charged with (a) Providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose E:\FR\FM\29OCN1.SGM 29OCN1

Agencies

[Federal Register Volume 75, Number 209 (Friday, October 29, 2010)]
[Notices]
[Pages 66767-66769]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-27330]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

Submission for OMB Review; Comment Request; Cancer Trials Support
Unit (CTSU) Public Use Forms and Customer Satisfaction Surveys (NCI)

SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Cancer Institute (NCI), the
National Institutes of Health (NIH), has submitted to the Office of
Management and Budget (OMB) a request to review and approve the
information collection listed below. This proposed information
collection was previously published in the Federal Register on July 13,
2010 (75 FR 39950) and allowed 60-days for public comment. There have
been no public comments. Additionally, the 30-day Federal Register was
published on September 13, 2010. The purpose of this notice is to allow
an additional 30 days for public comment to the revisions. The National
Institutes of Health may not conduct or sponsor, and the respondent is
not required to respond to, an information collection that has been
extended, revised, or implemented on or after October 1, 1995, unless
it displays a currently valid OMB control number.
Proposed Collection: Title: Cancer Trial Support Unit (CTSU). Type
of Information Collection Request: Existing Collection in Use Without
an OMB Number. Need and Use of Information Collection: CTSU collects
annual surveys of customer satisfaction for clinical site staff using
the CTSU Help Desk and the CTSU Web site. An ongoing user satisfaction
survey is in place for the Oncology Patient Enrollment Network (OPEN).
User satisfaction surveys are compiled as part of the project quality
assurance activities and used to direct improvements to processes and
technology. In addition, the CTSU collects standardized forms to
process site regulatory information, changes to membership, patient
enrollment data, and routing information for case report forms. This
questionnaire adheres to The Public Health Service Act, Section 413 (42
U.S.C. 285a-2) authorizes CTEP to establish and support programs to
facilitate the participation of qualified investigators on CTEP-
supported studies, and to institute programs that minimize redundancy
among grant and contract holders, thereby reducing overall cost of
maintaining a robust treatment trials program. Based on a conversation
with the Office of Management and Budget on October 17, 2010, the
burden table has been revised to take into account future submissions
of a generic data transmittal forms (see Attachment 1gg in the Table
below). It was agreed that the generic forms will be finalized and
submitted in the future as non-substantive change requests for OMB
clearance as needed. Frequency of Response: The help desk and Web site
survey are collected annually. The OPEN survey is ongoing. The form
submissions vary depending on the purpose of the form and the activity
of the local site. Affected Public: CTSU's target audience is staff
members at clinical sites and CTEP-supported programs. Respondent and
burden estimates are listed in the Table below. The annualized burden
is estimated to be 34,802 hours and the annualized cost to respondents
is estimated to be $946, 601. There are no Capital Costs, Operating
Costs, and/or Maintenance Costs to report.

--------------------------------------------------------------------------------------------------------------------------------------------------------
Use metrics/ Estimated time Estimated
month-- respond complete (minutes/ response usage/annual
(minutes) hours) burden hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Regulatory/Roster
--------------------------------------------------------------------------------------------------------------------------------------------------------
1a................................... CTSU IRB/Regulatory Approval 9,000 2 0.03 12.00 3,600
Transmittal Form.
1b................................... CTSU IRB Certification Form...... 8,500 10 0.17 12.00 17,000
1c................................... CTSU Acknowledgement Form........ 500 5 0.08 12.00 500
1d................................... Optional Form 1--Withdrawal from 50 5 0.08 12.00 50
Protocol Participation Form.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Roster Forms
--------------------------------------------------------------------------------------------------------------------------------------------------------
1e................................... CTSU Roster Update Form.......... 50 2-4 0.07 12.00 40
1f................................... CTSU Radiation Therapy Facilities 20 30 0.50 12.00 120
Inventory Form.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Drug shipment
--------------------------------------------------------------------------------------------------------------------------------------------------------

[[Page 66768]]

1g................................... CTSU IBCSG Drug Accountability 11 5-10 0.17 12.00 22
Form.
1h................................... CTSU IBCSG Transfer of 3 20 0.33 12.00 12
Investigational Agent Form.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Data Management
--------------------------------------------------------------------------------------------------------------------------------------------------------
1i................................... Site Initiated Data Update Form 100 5-10 0.17 12.00 200
(generic).
1j................................... N0147 CTSU Data Transmittal Form. 1000 5-10 0.17 12.00 2,000
1k................................... Site Intimated Data Update Form 75 5-10 0.17 12.00 150
(DUF), Protocol: NCCTG N0147*.
1l................................... TAILORX/PACCT 1 CTSU Data 2100 5-10 0.17 12.00 4,200
Transmittal Form.
1m................................... Data Clarification Form.......... 650 15-20 0.33 12.00 2,600
1n................................... Unsolicited Data Modification 75 5-10 0.17 12.00 150
Form (UDM), Protocol: TAILORx/
PACCT1.
1o................................... Z4032 CTSU Data Transmittal Form. 50 5-10 0.17 12.00 100
1p................................... Z1031 CTSU Data Transmittal Form. 50 5-10 0.17 12.00 100
1q................................... Z1041 CTSU Data Transmittal Form. 50 5-10 0.17 12.00 100
1r................................... Z6051 CTSU Data Transmittal Form. 75 5-10 0.17 12.00 150
1s................................... RTOG 0834 CTSU Data Transmittal 60 5-10 0.17 12.00 120
Form*.
1t................................... CTSU 7868 Data Transmittal Form.. 50 5-10 0.17 12.00 100
1u................................... Site Initiated Data Update Form, 10 5-10 0.17 12.00 20
protocol 7868.
1v................................... MC0845(8233) CTSU Data 50 5-10 0.17 12.00 100
Transmittal*.
1w................................... 8121 CTSU Data Transmittal Form*. 100 5-10 0.17 12.00 200
1x................................... Site Initiated Data Update Form, 10 5-10 0.17 12.00 20
Protocol 8121.
1y................................... USMCI 8214/Z6091: CTSU Data 50 5-10 0.17 12.00 100
Transmittal.
*In Development..................
1z................................... USMCI 8214/Z6091 Crossover 5 5-10 0.17 12.00 10
Request/Checklist Transmittal
Form.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Patient Enrollment
--------------------------------------------------------------------------------------------------------------------------------------------------------
1aa.................................. CTSU Patient Enrollment 600 5-10 0.17 12.00 1,200
Transmittal Form.
1bb.................................. CTSU P2C Enrollment Transmittal 30 5-10 0.17 12.00 60
Form.
1cc.................................. CTSU Transfer Form............... 40 5-10 0.17 12.00 80
--------------------------------------------------------------------------------------------------------------------------------------------------------
Administrative
--------------------------------------------------------------------------------------------------------------------------------------------------------
1dd.................................. CTSU System Account Request Form. 50 15-20 0.33 12.00 200
1ee.................................. CTSU Request for Clinical 35 10 0.17 12.00 70
Brochure.
1ff.................................. CTSU Supply Request Form......... 130 5-10 0.17 12.00 260
1gg.................................. CTSU Generic Data Transmittal 500 5-10 0.17 12.00 1000.00
Form.
--------------------------------------------------------------------------------------------------------------------------------------------------------
Surveys/Web Forms
--------------------------------------------------------------------------------------------------------------------------------------------------------
2.................................... CTSU Web Site Customer 250 10-15 0.2500 1.00 63
Satisfaction Survey.
3.................................... CTSU Helpdesk Customer 300 10-15 0.2500 1.00 75
Satisfaction Survey.
4.................................... CTSU OPEN Survey................. 120 10-15 0.2500 1.00 30
-------------------------------------------------------------------------------
Annual Totals
21,770........................... .............. .............. .............. .............. 34,802
--------------------------------------------------------------------------------------------------------------------------------------------------------

Request for Comments: Written comments and/or suggestions from the
public and affected agencies should address one or more of the
following points: (1) Evaluate whether the proposed collection of
information is necessary for the proper performance of the function of
the agency, including whether the information will have practical
utility; (2) Evaluate the accuracy of the agency's estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used; (3) Enhance the
quality, utility, and clarity of the information to be collected; and
(4) Minimize the burden of the collection of information on those who
are to respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the Attention: NIH Desk Officer, Office of Management and
Budget, at OIRA_submission@omb.eop.gov or by fax to 202-395-6974. To
request more information on the proposed project or to obtain a copy of
the data collection plans and instruments, contact Michael Montello,
Pharm. D., CTEP, 6130 Executive Blvd., Rockville, MD 20852, call non-
toll-free number 301-435-9206 or e-mail your request, including your
address to: montellom@mail.nih.gov.

[[Page 66769]]

Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30 days
of the date of this publication.

Dated: October 21, 2010.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2010-27330 Filed 10-28-10; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.